Minimally Invasive Treatment Technique
Treatment Solution
Laser ablation is a minimally invasive treatment technique that uses focused laser energy delivered through a fine optical fiber to target selected tissue with precision. Depending on the clinical application, laser energy may be used to cut, vaporize, shrink, coagulate, or seal tissue while helping to reduce unnecessary trauma to surrounding areas.
At Healthcon, this treatment option is supported by GigaaMed medical laser technology, designed for use across multiple specialties including ENT, Gynaecology, Urology, PLDD, and BPH management. GigaaMedical lists surgical laser applications including ENT, gynaecology, urology and PLDD among its medical laser product areas.
What is BPH and Prostate Tumor?
BPH, or Benign Prostatic Hyperplasia, is a non-cancerous enlargement of the prostate that can narrow the urinary channel and cause symptoms such as weak urine flow, frequent urination, urgency, and incomplete bladder emptying. Prostate tumors involve abnormal tissue growth within the prostate and may require careful evaluation to determine the most suitable treatment approach. In selected prostate conditions, laser technology may be used to remove, vaporize, or ablate targeted tissue through a minimally invasive endoscopic approach.
How GigaaMed Laser Ablation Treats BPH and Prostate Tumors
GigaaMed laser technology can be used with a cystoscope to deliver laser energy directly to targeted prostate tissue. The laser energy may support controlled tissue cutting, vaporization, coagulation, or ablation depending on the clinical requirement.
For BPH, laser energy may help remove or reduce obstructive prostate tissue, supporting improved urinary flow in selected patients. For prostate tumor applications, laser energy may be used for precise tissue ablation in selected cases, depending on patient assessment, treatment planning, and specialist decision.
The GigaaMed reference highlights the use of 980nm and 1470nm dual-wavelength laser for prostate-related treatment, where 1470nm supports water absorption for tissue cutting, while 980nm supports coagulation and reduced bleeding.
Key Benefits
- Minimally invasive endoscopic approach
- Supports prostate tissue vaporization and ablation
- Helps improve urinary flow in selected BPH cases
- Controlled tissue cutting with coagulation support
- May help reduce bleeding during treatment
- Dual-wavelength option for cutting and coagulation
- Supports shorter recovery pathway in selected patients
- Suitable for selected BPH and prostate tumor applications
